Back to search

Netherlands· NL-220e94578923

Tamoxifen Aurobindo 20 mg, tabletten

A tamoxifen product containing tamoxifencitraat, registered in Netherlands by Aurobindo Pharma B.V.. The same ATC class is registered in 17 of our 19 countries.

ATC L02BA01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedTamoxifen Aurobindo 20 mg, tablettenATCL02BA01REGISTER NO.NL-220e94578923PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Tamoxifen is registered in 17 of 19 countries.

Countries holding a registration under ATC L02BA01 (tamoxifen), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 10 of them publish a price we can compare per daily dose

Tamoxifen · ATC L02BA01

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of tamoxifen costs, country by country.

Normalised to the WHO defined daily dose (20 mg), the median price runs from $0.25 in France to $1.04 in Switzerland — a ×4.2 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Tamoxifen · price per daily dose (20 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$1.04
  • IT Italy$0.26
  • FR France$0.25
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
TAMOXIFENCITRAAT
Manufacturer
Aurobindo Pharma B.V.
Country
Netherlands (NL)
ATC code
L02BA01
ATC class
Tamoxifen
Defined daily dose
20 mg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    17116=10635

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

686 interactions on record for tamoxifen.

Graded by severity as the source publishes them — 128 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Tamoxifen · interactions on record

686 records

  • 128 severe
  • 317 moderate
  • 13 minor
  • 197 info

Most severe, free to view

  • CimetidineA02BA01severe
  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe

31 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Tamoxifen in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tamoxifen products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Ebefen, Nolvadex
  • Belgium · Nolvadex, Nolvadex-D
  • Bulgaria · Нолвадекс, Тамоксифен Софарма
  • Cyprus · Nolvadex, Nolvadex D
  • Czechia · Tamoxifen Ebewe
  • Germany · Nolvadex, Tamoxifen Abz
  • Denmark · Tamoxifen "sandoz", Tamoxifen Mylan
  • Estonia · Tamoxifen Ebewe
  • Spain · Tamoxifeno, Tamoxifeno Cinfa
  • Finland · Tadex
  • France · Nolvadex, Tamoxifene Arrow
  • United Kingdom (Northern Ireland) · Nolvadex, Nolvadex D
  • Greece · Adifen, Adifen 10mg
  • Croatia · Nolvadex
  • Hungary · Zitazonium
  • Ireland · Tamox, Tamoxifen Generics [uk] Limited
  • Iceland · Tamoxifen Viatris
  • Italy · Kessar, Nolvadex
  • Lithuania · Tamoxifen Ebewe
  • Luxembourg · Nolvadex, Nolvadex-D
  • Latvia · Tamoxifen Orion
  • Malta · Novofen, Tamox
  • Norway · Tamoxifen Mylan
  • Poland · Tamoxifen Ebewe, Tamoxifen Egis
  • Portugal · Tamoxan, Tamoxifeno Farmoz
  • Romania · Tamoxifen
  • Sweden · Tamoxifen Orifarm, Tamoxifen Sandoz
  • Slovenia · Nolvadex
  • Slovakia · Tamoxifen Sandoz, Zitazonium

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e467ab09-20cf-4314-baf2-dc03444224a4
GET /v1/drugs/e467ab09-20cf-4314-baf2-dc03444224a4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h10635_smpc.pdf",
  "strength": null,
  "atc_label": "Tamoxifen",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg17116",
  "excipients": [
    "AARDAPPELZETMEEL",
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "LACTOSE 1-WATER",
    "MAGNESIUMSTEARAAT (E 470b)",
    "POVIDON K 25 (E 1201)",
    "SILICIUMDIOXIDE (E 551)"
  ],
  "substances": [
    "TAMOXIFENCITRAAT"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h17116.pdf",
  "authorised_at": "1993/09/27",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "17116=10635",
  "additional_monitoring": "N"
}

See everything about tamoxifen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.